Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ixabepilone in taxane-resistant metastatic breast cancer
NCT01019577Phase 2Completed
- Sponsor
- R-Pharm
- Start
- Oct 2005
- Primary completion
- Jul 2007
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of ixabepilone in breast cancer, sponsored by R-Pharm. Started Oct 2005; status: completed.
02
Drugs
ixabepilone
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT01019577.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01019577.